The U.S. Health and Human Services Office of Inspector General (OIG) has their compliance eyes on a couple dermatology issues you need to know about. The first involves medical coding modifier 25 and the second is about skin substitutes.
Healthicity Blog
Subscribe for Healthcare News, Simplified.
Posts about whitepaper:
Behavioral Health Compliance Under Scrutiny: Recent Enforcement Actions and Lessons Learned
C-Suite Accountability: The DOJ’s New Focus on Healthcare Executives
Education and Training Tips for Your Compliance Program
How to Create a Non-Retaliation Policy
The Health and Human Services Office of Inspector General (OIG) recently published General Compliance Program Guidance1, and one of the many important sections in the document includes a list of a compliance officer’s primary responsibilities. Among these primary responsibilities is the development...
How to Create an Annual Audit Plan
Traditionally, as the calendar year approaches its end, many compliance programs evaluate their annual audit plan to assess its effectiveness and revise the plan as needed for the following year. Some compliance programs may do this at other times of the year. When it happens is not as essential as...
Why Multiple Agencies are Scrutinizing the Use of Psychotropic Medications in Nursing Homes
In November 2022, the U.S. Health and Human Services (HHS) Office of Inspector General (OIG) issued a report titled, “Long-Term Trends of Psychotropic Drug Use in Nursing Homes.”1 This report highlights areas of weakness related to nursing home patients who may be inappropriately given psychotropic...